Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin

Introduction | Browse | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA04000038 19(20) EpDPE cPLA2i 1.0 BCD110605C28 0.389 pmol/ml medium
LMFA04000038 19(20) EpDPE cPLA2i 1.0 BCD110605C30 0.344 pmol/ml medium
LMFA04000038 19(20) EpDPE cPLA2i 1.0 BCD110605C29 0.367 pmol/ml medium
LMFA04000038 19(20) EpDPE cPLA2i 20.0 BCD110605C64 0.825 pmol/ml medium
LMFA04000038 19(20) EpDPE cPLA2i 20.0 BCD110605C66 0.843 pmol/ml medium
LMFA04000038 19(20) EpDPE cPLA2i 20.0 BCD110605C65 0.81 pmol/ml medium
LMFA04000038 19(20) EpDPE PLDi 1.0 BCD110605C16 0.334 pmol/ml medium
LMFA04000038 19(20) EpDPE PLDi 1.0 BCD110605C17 0.323 pmol/ml medium
LMFA04000038 19(20) EpDPE PLDi 1.0 BCD110605C18 0.347 pmol/ml medium
LMFA04000038 19(20) EpDPE PLDi 20.0 BCD110605C54 1.01 pmol/ml medium
LMFA04000038 19(20) EpDPE PLDi 20.0 BCD110605C52 1.12 pmol/ml medium
LMFA04000038 19(20) EpDPE PLDi 20.0 BCD110605C53 1.03 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+cPLA2i 1.0 BCD110605C32 0.389 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+cPLA2i 1.0 BCD110605C31 0.353 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+cPLA2i 1.0 BCD110605C33 0.369 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+cPLA2i 20.0 BCD110605C68 0.708 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+cPLA2i 20.0 BCD110605C69 0.757 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+cPLA2i 20.0 BCD110605C67 0.694 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+PLDi 1.0 BCD110605C19 0.365 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+PLDi 1.0 BCD110605C20 0.291 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+PLDi 1.0 BCD110605C21 0.272 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+PLDi 20.0 BCD110605C56 0.843 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+PLDi 20.0 BCD110605C57 0.926 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+PLDi 20.0 BCD110605C55 0.812 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.355 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.247 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.32 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.553 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.48 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.578 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+PLDi 1.0 BCD110605C25 0.291 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+PLDi 1.0 BCD110605C27 0.307 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+PLDi 1.0 BCD110605C26 0.264 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+PLDi 20.0 BCD110605C61 0.46 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+PLDi 20.0 BCD110605C62 0.416 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO+ATP+PLDi 20.0 BCD110605C63 0.458 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO + ATP 1.0 BCD110605C15 0.312 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO + ATP 1.0 BCD110605C14 0.317 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO + ATP 1.0 BCD110605C13 0.272 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO + ATP 20.0 BCD110605C49 0.547 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO + ATP 20.0 BCD110605C50 0.543 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO + ATP 20.0 BCD110605C51 0.527 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO 1.0 BCD110605C08 0.277 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO 1.0 BCD110605C07 0.287 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO 1.0 BCD110605C09 0.316 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO 20.0 BCD110605C45 0.962 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO 20.0 BCD110605C44 0.854 pmol/ml medium
LMFA04000038 19(20) EpDPE KDO 20.0 BCD110605C43 0.928 pmol/ml medium
LMFA04000038 19(20) EpDPE C 0.0 BCD110605C03 0.347 pmol/ml medium
LMFA04000038 19(20) EpDPE C 0.0 BCD110605C01 0.363 pmol/ml medium